Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health

Written by

Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health

SAN DIEGO--(BUSINESS WIRE)--Biolinq Incorporated, a healthcare technology company pioneering precision multi-analyte biosensors to improve metabolic health, today announced a $100 million Series C financing led by Alpha Wave Ventures, with participation from existing investors RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical and Features Capital.

The funding will support Biolinq through the US regulatory approval process as the company prepares to bring the first autonomous intradermal glucose sensor to market.

Full article here: https://www.businesswire.com/news/home/20250422298486/en/Biolinq-Announces-Close-of-$100M-Series-C-Financing-to-Advance-Its-Biowearable-Platform-for-Metabolic-Health

Other news

Mass Device

June 2, 2024

Biolinq raises $58M to support intradermal glucose sensor

Biolinq announced today that it completed $58 million financing to support the progression of its proprietary intradermal glucose sensor. Alpha Wave Ventures led the funding round. Niterra’s corporate venture capital fund jointly operated with Pegasus Tech Ventures also participated.

Biolinq: Less pain, $58m gain for tiny glucose sensor

In a sweet indication of an improving capital market for med-tech companies, Biolinq Inc. landed $58 million in bridge financing to support completion of the U.S. pivotal trial of its intradermal glucose sensor and submission to the U.S. FDA.

Written by

Anette Boyle

Medical Device Network

June 2, 2024

Biolinq raises $58m for glucose microsensor pivotal trial

Biolinq is eying an FDA application this year, according to CEO Richard Yang. “The pivotal study started in March 2024 and we plan to file for US Food and Drug Administration (FDA) clearance this year.” said Yang.

Written by

Robert Barrie